2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Epitranscriptomic addition of m 5C to HIV-1 transcripts regulates viral gene expression

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          How the covalent modification of mRNA ribonucleotides, termed epitranscriptomic modifications, alters mRNA function remains unclear. One issue has been the difficulty of quantifying these modifications. Using purified HIV-1 genomic RNA, we show that this RNA bears more epitranscriptomic modifications than the average cellular mRNA, with 5-methylcytosine (m 5C) and 2’O-methyl modifications being particularly prevalent. The methyltransferase NSUN2 serves as the primary writer for m 5C on HIV-1 RNAs. NSUN2 inactivation not only inhibits m 5C addition to HIV-1 transcripts but also viral replication. This inhibition results from reduced HIV-1 protein, but not mRNA, expression, which in turn correlates with reduced ribosome binding to viral mRNAs. In addition, loss of m 5C dysregulates the alternative splicing of viral RNAs. These data identify m 5C as a post-transcriptional regulator of both splicing and function of HIV-1 mRNA, thereby affecting directly viral gene expression.

          Graphical Abstract

          In Brief

          Courtney et al. report that HIV-1 transcripts are modified by the addition of 5-methylcytosine (m 5C) residues. The nuclear methyltransferase NSUN2 is the primary m 5C writer and is required for appropriate HIV-1 translation. NSUN2 deficiency, and concomitant loss of m 5C residues, inhibits ribosomal recruitment to and alternative splicing of HIV-1 mRNAs.

          Related collections

          Author and article information

          Journal
          101302316
          33345
          Cell Host Microbe
          Cell Host Microbe
          Cell host & microbe
          1931-3128
          1934-6069
          5 August 2019
          14 August 2019
          14 August 2020
          : 26
          : 2
          : 217-227.e6
          Affiliations
          [1 ]Dept. of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
          [2 ]Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
          [3 ]Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514
          [4 ]Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514
          [5 ]Lead contact
          Author notes
          [* ]Correspondence: bryan.cullen@ 123456duke.edu

          Author Contributions

          Conceptualization, D.G.C., E.M.K., and B.R.C.; Methodology, D.G.C., H.P.B, K.T., E.M.K., B.A.L., A.E., and B.R.C.; Formal Analysis, D.G.C., K.T., E.M.K., and A.E.; Investigation, D.G.C., H.P.B., K.T., E.M.K., B.A.L., and A.E.; Writing – Original Draft, D.G.C., and B.R.C.; Writing – Review & Editing, D.G.C., K.T., H.P.B., E.M.K., R.S., C.L.H., and B.R.C.; Supervision, R.S., C.L.H, and B.R.C.; Funding Acquisition, D.G.C., R.S., and B.R.C.

          [#]

          Current address: Oncorus, 50 Hampshire Street, Suite 401, Cambridge MA 02139

          Article
          PMC6714563 PMC6714563 6714563 nihpa1535877
          10.1016/j.chom.2019.07.005
          6714563
          31415754
          4a21fcdf-b6dd-4f12-a0af-24a914f10e7e
          History
          Categories
          Article

          Comments

          Comment on this article